A recent report alleged that the former drug company executive was helping run his firm using a contraband cellphone.
Martin Shkreli, former chief executive officer of Turing Pharmaceuticals and KaloBios Pharmaceuticals Inc, arrives for his trial on July 21, 2017.Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings.NEW YORK - The U.S.
Shkreli, born in Brooklyn to Albanian immigrant parents, became known as the"Pharma Bro" in September 2015 after founding Turing Pharmaceuticals, buying the anti-parasitic drug Daraprim and raising its price by 5,000 percent to $750 per pill. In December 2015, he was indicted on unrelated securities fraud charges.he ran, MSMB Capital and MSMB Healthcare, schemed to prop up the stock price of Retrophin, the drug company he founded in 2011.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Feds probe alleged prison cellphone use by 'Pharma Bro'Federal authorities said Friday they are investigating claims that Martin Shkreli has been running his pharmaceutical company from behind bars using a contraband smartphone. The U.S. Bureau of Prisons told The Associated Press it has opened an inquiry into whether the man nicknamed the 'Pharma
Weiterlesen »
Prison authorities say they are investigating 'pharma bro' ShkreliThe U.S. Bureau of Prisons said on Friday it was investigating former drug compa...
Weiterlesen »
Exclusive: OxyContin maker Purdue Pharma exploring bankruptcy - sourcesOxyContin maker Purdue Pharma LP is exploring filing for bankruptcy to address p...
Weiterlesen »
Why Big Pharma Is Diving Into Gene TherapyBarron's cover story: Big Pharma is diving into gene therapy
Weiterlesen »
OxyContin maker Purdue Pharma loses bid to delay opioid epidemic trialOxyContin maker Purdue Pharma LP and two other drugmakers on Friday lost a bid t...
Weiterlesen »
Deploying drugs for new purposes holds great promiseRepurposing drugs is a cheaper way of fighting diseases
Weiterlesen »
Purdue Pharma says opioid lawsuit by Mass. attorney general amounts to ‘oversimplified scapegoating’The suit alleges that Purdue disregarded safety and pushed doctors to prescribe high doses of OxyContin.
Weiterlesen »
Historic trial against Big Pharma will start in May, judge saysAn Oklahoma judge ruled Friday that a historic opioid trial against several major pharmaceutical companies will begin May 28, rejecting their motion to delay the trial.
Weiterlesen »
Oxycontin-maker Purdue Pharma reportedly exploring bankruptcy amid litigation over opioidsOxyContin-maker Purdue Pharma is exploring filing for bankruptcy amid thousands of lawsuits alleging the drug manufacturer contributed to the deadly opioid crisis sweeping the US, according to Reuters.
Weiterlesen »